Relation of Proton Pump Inhibitor Use After Percutaneous Coronary Intervention With Drug-Eluting Stents to Outcomes
February 7th, 2010 Posted by: admin
Publication year: 2010
Source: The American Journal of Cardiology, In Press, Corrected Proof, Available online 5 February 2010
Michael A., Gaglia Jr. , Rebecca, Torguson , Nicholas, Hanna , Manuel A., Gonzalez , Sara D., Collins , …
Recent evidence has shown that clopidogrel and proton pump inhibitors (PPIs) are metabolized by the same pathway and that patients taking both drugs have greater levels of platelet reactivity and more adverse outcomes than patients taking only clopidogrel. We sought to examine the effect of a PPI at discharge from the hospital after percutaneous coronary intervention with drug-eluting stents on the incidence of major adverse cardiac events (MACE) at 1 year. We compared 502 patients who were not prescribed a PPI at discharge and 318 patients who were prescribed a PPI. All patients were taking clopidogrel. We followed patients for…
Similar Posts:
- Prevalence of Aspirin and Clopidogrel Resistance Among Patients With and Without Drug-Eluting Stent Thrombosis
- Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
- Relation Between Red Cell Distribution Width and Clinical Outcomes After Acute Myocardial Infarction
- A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
- Alcohol Biomarkers in Patients Admitted for Trauma
- Impact of Alpha 1-Adrenergic Antagonist Use for Benign Prostatic Hypertrophy on Outcomes in Patients With Heart Failure
- Usefulness of Cystatin C and Prognosis Following Admission for Acute Heart Failure
- Safety and In-Hospital Outcomes of Bivalirudin Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention
- Baseline Low-Density Lipoprotein Cholesterol Levels and Outcome in Patients With Heart Failure
- Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients